The report provides a detailed analysis essential for establishing a Tripelennamine production plant. It encompasses all critical aspects necessary for Tripelennamine production, including the cost of Tripelennamine production, Tripelennamine plant cost, Tripelennamine production costs, and the overall Tripelennamine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Tripelennamine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Tripelennamine is a first-generation antihistamine that helps block the effects of histamine in the body. It helps to ease common allergy symptoms like itchy skin, sneezing, runny nose, watery eyes, and hives from hay fever or insect bites. It is used for treating allergic rhinitis, asthma attacks triggered by allergies, and upper respiratory issues from colds and skin reactions.
It is taken as pills, ointments, creams for rashes, cough syrups mixed with other ingredients, or injections for quick relief in bad reactions. It works by sticking to histamine receptors in the nose, lungs, blood vessels, and skin to stop swelling, itching, and breathing trouble. Its common side effects of Tripelennamine include drowsiness, dry mouth, dizziness, nausea, headache, and stomach upset.
The market for Tripelennamine is driven by its status as an inexpensive generic first-generation antihistamine. Its utilisation in allergy symptom relief, like hay fever, hives, and rhinitis, contributes to its market growth. Its usage in combination with cough syrups with expectorants or codeine for upper respiratory issues, topical creams for insect bites and skin pruritus, boosts its demand.
The presence of GMP-compliant API manufacturers and exporters with USDMF, EDQM CEP, or WHO certifications impacts industrial Tripelennamine procurement. Also, stable shelf-life logistics to prevent degradation in humid climates, and flexible minimum order quantities to support hospital formulary needs without overstock risks impact its sourcing.
Raw Material for Tripelennamine Production
According to the Tripelennamine production plant project report, the key raw materials used in the production of Tripelennamine include 2-aminopyridine, benzyl chloride, and 2-dimethylaminoethyl chloride.
Production Process of Tripelennamine
The extensive Tripelennamine production cost report consists of the following major industrial production process:
- By N-Alkylation: The production of Tripelennamine involves a sequential N-alkylation of 2-aminopyridine. First, 2-aminopyridine is treated with sodium hydride in toluene to form its sodium salt. To this mixture, benzyl chloride is added and refluxed until completion, followed by workup and purification to yield the N-benzyl-2-aminopyridine intermediate. Next, the process is repeated with the intermediate using sodium hydride in toluene, and 2-dimethylaminoethyl chloride is added and refluxed to form Tripelennamine free base, which is isolated by extraction and distillation.
Tripelennamine appears as a white, bitter crystalline powder with a molecular formula of C16H21N3 and a molecular weight of 255.36 g/mol. It has a melting point at 188-192 degree Celsius with a boiling point between 193-205 degree. It has a density of around 1.0683 g/cm³ and a refractive index between 1.5759 and 1.5765. Its LogP values range between 3.05 and 3.3, showing its lipophilicity. It competitively blocks H1 histamine receptors as a weak SNDRI with pKa 3.90 and 8.68, polar surface area 19.37 Ų. It has 2 rings, 6 rotatable bonds, no hydrogen donors, acidic solutions to litmus, and shows stability except against strong oxidants.
